Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Delova Biotech | 2024 | Series B | $13.8M | Qixia |
| Uditech | 2024 | Series Unknown | Undisclosed | Shenzhen |
| Akulaku Group | 2024 | Debt Financing | $100.0M | Jakarta |
| varnotech | 2024 | Series B | $83.0M | Beijing |
| ESWIN Computing | 2024 | Private Equity | Undisclosed | Beijing |
| Rhino Medical | 2023 | Series A | $14.0M | Hangzhou |
| Intelligence Indeed | 2023 | Series C | $28.0M | Hangzhou |
| Lingtai Krypton Biotechnology | 2023 | Seed | $13.7M | Shuangliu |
| Rxilient | 2023 | Series Unknown | $30.0M | Singapore |
| Saige Research | 2023 | Series B | $11.6M | Seoul |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Delova Biotech | Series B | $13.8M | Qixia, China |
| 77 | Uditech | Series Unknown | Undisclosed | Shenzhen, China |
| 78 | Akulaku Group | Debt Financing | $100.0M | Jakarta, Indonesia |
| 79 | varnotech | Series B | $83.0M | Beijing, China |
| 80 | ESWIN Computing | Private Equity | Undisclosed | Beijing, China |
| 81 | Rhino Medical | Series A | $14.0M | Hangzhou, China |
| 82 | Intelligence Indeed | Series C | $28.0M | Hangzhou, China |
| 83 | Lingtai Krypton Biotechnology | Seed | $13.7M | Shuangliu, China |
| 84 | Rxilient | Series Unknown | $30.0M | Singapore, Singapore |
| 85 | Saige Research | Series B | $11.6M | Seoul, South Korea |
Delova Biotech specializes in the field of pain treatment.
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.
Akulaku is a banking and digital finance platform that provides a variety of virtual payment services.
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.
ESWIN Computing provides research and development of RISC-V computing architecture.
Rhino Medical develops an advanced technologies with independent intellectual property rights.
Intelligence Indeed is an artificial intelligence enterprise for decision-making field of large-scale and complex problems.
Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Rxilient provides pharmaceutical CDMO services.
Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Ligatech Bioscience is an intrusive consumables developer .
Jinqirui Biology is a biotech company that focuses on the R&D, production & sales of vitro diagnostics equipment and reagents.
using.ai is an AI application service provider that specializes in machine vision, robotics learning and machine learning.
Singlomics uses single-cell sequencing technology for antibody drug discovery.
CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
Digital Enhancement is a high-performance DFE solution provider.
VectorBuilder is an online platform for vector cloning and other CRO services.
Bio-Engine is a biotechnology company that develops a bio-technical platform to research and develop animal cells.
DentaFilm is a provider of oral intelligent equipment and a full-chain platform, focusing on the advancement of digital cloud platforms.
A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.
Muniu Technology is a radar sensor system developer.
Reliable Med is a medical device developer.
Hemu (China) Biological Engineering is a blood vessel intervention medical equipment firm.
Bespin Global provides consulting, migration, managed services and solutions for hybrid cloud.
Legend Capital has invested in 203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Legend Capital's top investment sectors include Biotechnology, Medical, Health Care, Information Technology, Pharmaceutical. The firm invests across 39 different industry categories.
Among tracked funding rounds, Akulaku Group received $100.0M in a Debt Financing round. Legend Capital's total known invested capital is $4.9B.
Legend Capital's average investment size is $37.7M across its portfolio of 203 companies.
Recent Legend Capital portfolio additions include Delova Biotech, Uditech, Akulaku Group, varnotech, ESWIN Computing. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors